- Home
- EQBK vs GRAL Comparison
EQBK vs GRAL Comparison
Compare EQBK & GRAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQBK
- GRAL
- Stock Information
- Founded
- EQBK 2002
- GRAL 2016
- Country
- EQBK United States
- GRAL United States
- Employees
- EQBK N/A
- GRAL N/A
- Industry
- EQBK Major Banks
- GRAL
- Sector
- EQBK Finance
- GRAL
- Exchange
- EQBK Nasdaq
- GRAL NYSE
- Market Cap
- EQBK 750.4M
- GRAL 610.9M
- IPO Year
- EQBK 2015
- GRAL N/A
- Fundamental
- Price
- EQBK $43.12
- GRAL $17.42
- Analyst Decision
- EQBK Hold
- GRAL Hold
- Analyst Count
- EQBK 4
- GRAL 2
- Target Price
- EQBK $44.50
- GRAL $16.00
- AVG Volume (30 Days)
- EQBK 84.6K
- GRAL 967.8K
- Earning Date
- EQBK 01-22-2025
- GRAL 02-15-2025
- Dividend Yield
- EQBK 1.25%
- GRAL N/A
- EPS Growth
- EQBK N/A
- GRAL N/A
- EPS
- EQBK 1.12
- GRAL N/A
- Revenue
- EQBK $157,755,000.00
- GRAL $117,669,000.00
- Revenue This Year
- EQBK N/A
- GRAL $32.48
- Revenue Next Year
- EQBK $6.05
- GRAL $14.72
- P/E Ratio
- EQBK $38.46
- GRAL N/A
- Revenue Growth
- EQBK N/A
- GRAL 111.83
- 52 Week Low
- EQBK $30.44
- GRAL $12.33
- 52 Week High
- EQBK $50.85
- GRAL $24.92
- Technical
- Relative Strength Index (RSI)
- EQBK 50.11
- GRAL N/A
- Support Level
- EQBK $39.26
- GRAL N/A
- Resistance Level
- EQBK $43.27
- GRAL N/A
- Average True Range (ATR)
- EQBK 1.07
- GRAL 0.00
- MACD
- EQBK 0.28
- GRAL 0.00
- Stochastic Oscillator
- EQBK 85.02
- GRAL 0.00
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. The company's operation involves the delivery of loan and deposit products to customers. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.
About GRAL GRAIL INC
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages.